Community Investing Ideas

Global Weekly Picks

US$21.48
129.7% overvalued intrinsic discount
Fair Value
Profit Margin
12.46%
Future PE
17.06x
Price in 2031
US$32.76
MDT logo
Medtronic

Strong in favor of diversity in value portfolio

Diversification in my portfolio meant investing in the healthcare sector. I already owned Pfizer.Read more

View narrative
US$90.37
10.0% undervalued intrinsic discount
Fair Value
Revenue
11% p.a.
Profit Margin
13.2%
Future PE
21.75x
Price in 2031
US$136.39
US$640
7.6% undervalued intrinsic discount
Fair Value
Forward EPS model: Starting from trailing EPS of $10.36 (Price $591 ÷ PE 57x), applying a weighted average earnings growth of +45% for 2026 and +23% for 2027 across top holdings (MU, AMD, MRVL, NVDA, AVGO, INTC weighted by fund allocation), yielding a 2027E EPS of $18.55. Applying a fair forward PE of 30x (semiconductor historical mid-cycle 28–35x, plus 3x AI structural premium, minus hype compression vs. today's 57x). Base price: $556. Adding $1.60 annual dividend and a 16% sector sentiment premium for a confirmed AI infrastructure cycle. Cross-checked against a 5.0x forward P/S multiple on 2027E revenues (+25% growth), yielding ~$545. Blended fair value: $640 by EOY 2027.